Demonstrating its ongoing commitment to whole-person care, Priority Health announces its newest partnership, which emphasizes the individualized importance of the fertility journey.
Grand Rapids, Michigan — Reproductive health, hormonal health support, and family-building assistance from Carrot Fertility will become available to Priority Health’s more than 1.3 million members in Michigan beginning January 1, 2025, following today’s announcement of their partnership that focuses on reproductive health care and support.
The entirety of the reproductive and pregnancy journey will be represented, from the time leading up to pregnancy to parenting to menopause, and both fully funded and self-funded employer groups will be able to choose from 2 plan options that cover such services as gestational surrogacy, adoption, and low testosterone.
Through this partnership, there will be 2 plan choices: Carrot Core and Carrot Pro. | Image Credit: © Carrot Fertility
"We’re honored to partner with Priority Health and increase access to fertility, family-building, and hormonal health support for people across Michigan,” said Adam Johnson, chief strategy officer at Carrot Fertility. “Through this partnership, we will help more employers lower overall health care costs while driving healthy outcomes for their employees.”
For more information, including thoughts from Rick Abbott, senior vice president of employer solutions for Priority Health, please click here.
For recent news on other innovative whole-person health plan offerings from Priority Health, click to read about the partnership with Sword Health that will offer customized care for musculoskeletal condition beginning November 1 and the collaboration with HealthBar that will see the introduction of health care and wellness offerings for Priority Health’s employees and their families.
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More